DJ

Deepti Jaiswal

Active Director Director DIN 10166094
DIN 10166094 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Deepti Jaiswal

Data last updated:

Deepti Jaiswal is a Director at Syncare Biotech Private Limited (since 2023). Syncare Biotech Private Limited reported revenue of ₹5.1 Lakh (FY 2025).

DIN 10166094
Primary Designation Director
First Appointment 17 May 2023
Oldest Company Age 3 yrs
Largest company Syncare Biotech Private Limited · ₹5.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Syncare Biotech Private Limited U46692MP2023PTC065804
Director17 May 20232023₹5.1 Lakh (FY 2025)Active

Board colleagues of Deepti Jaiswal

NameDINCompanyDesignation
Mithilesh Kumar Jaiswal10166093Syncare Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Syncare Biotech Private Limited
Premium access

Shareholding and investment profile for Deepti Jaiswal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepti Jaiswal

Deepti Jaiswal currently holds 1 directorship: Syncare Biotech Private Limited (Director, since 17 May 2023, revenue ₹5.1 Lakh (FY 2025)).

Deepti Jaiswal was first appointed on 17 May 2023 as Director at Syncare Biotech Private Limited.

The current boards of Deepti Jaiswal's companies include Mithilesh Kumar Jaiswal (Syncare Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available